In triple-negative breast cancer, gastric cancer, and glioma, SNHG12 is high in expression (Lan et al., 2017; Wang et al., 2017; Zhang and Lu, 2018, 12; Zhou et al., 2018, 12; Tamang et al., 2019, 12). This evidence concerns the gene SNHG12 and central nervous system cancer.